Bausch & Lomb – Startup Investor Profile

Bausch & Lomb is an eye health company bringing visionary Ideas to Eye Health.

Location: Rochester

Country:

Investment Regions:

Investment Stages: late-stage

Website: http://www.bausch.com/

AI Reasoning: Search results show Bausch & Lomb made acquisitions/transactions with filings in June 2025 (Form 8-K) and activity in 2024 and 2025, but no clear record of a startup investment within the last 3 months. The most recent documented corporate transaction (SEC filing) is June 26, 2025. That is more than 4 months before the reference date, which places the last known investment/transaction beyond the 3-month very-active window but within 12 months. However, the classification criteria: ‘active’ is 6-3 months, ‘low-active’ is 12-6 months, and ‘not-active’ is >12 months. The June 26, 2025 activity is 4 months prior, which falls into the ‘active’ (between 6 and 3 months) category. But the evidence refers to acquisitions rather than direct startup investments; the specific startup named in filings includes Eyeonics (historic) and mentions LENZ Therapeutics in 2024. Given ambiguity and lack of a clear recent startup investment within 6 months, defaulting to ‘not-active’ per conservative rule is incorrect. Adjusting: the June 26, 2025 SEC filing documents a transaction (subsidiary acquisition) – since this is within 6 months to 3 months window (about 4 months), the correct tag is ‘active’.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.